000			01807 a2200529 4500
005			20250516142419.0
264		0	_c20131025
008			201310s 0 0 eng d
022			_a1949-2553
024	7		_a10.18632/oncotarget.930 _2doi
040			_aNLM _beng _cNLM
100	1		_aYan, Shuang
245	0	0	_aInhibition of STAT3 with orally active JAK inhibitor, AZD1480, decreases tumor growth in Neuroblastoma and Pediatric Sarcomas In vitro and In vivo. _h[electronic resource]
260			_bOncotarget _cMar 2013
300			_a433-45 p. _bdigital
500			_aPublication Type: Journal Article; Research Support, N.I.H., Intramural
650	0	4	_aAnimals
650	0	4	_aApoptosis _xdrug effects
650	0	4	_aCaspases
650	0	4	_aCell Cycle _xdrug effects
650	0	4	_aCell Line
650	0	4	_aCell Line, Tumor
650	0	4	_aCell Survival _xdrug effects
650	0	4	_aChild
650	0	4	_aDose-Response Relationship, Drug
650	0	4	_aFemale
650	0	4	_aHEK293 Cells
650	0	4	_aHumans
650	0	4	_aImmunoblotting
650	0	4	_aJanus Kinase 2 _xantagonists & inhibitors
650	0	4	_aMice
650	0	4	_aMice, Nude
650	0	4	_aMice, SCID
650	0	4	_aNeuroblastoma _xdrug therapy
650	0	4	_aPyrazoles _xadministration & dosage
650	0	4	_aPyrimidines _xadministration & dosage
650	0	4	_aSTAT3 Transcription Factor _xmetabolism
650	0	4	_aSarcoma _xdrug therapy
650	0	4	_aSignal Transduction _xdrug effects
650	0	4	_aSurvival Analysis
650	0	4	_aTumor Burden _xdrug effects
650	0	4	_aXenograft Model Antitumor Assays
700	1		_aLi, Zhijie
700	1		_aThiele, Carol J
773	0		_tOncotarget _gvol. 4 _gno. 3 _gp. 433-45
856	4	0	_uhttps://doi.org/10.18632/oncotarget.930 _zAvailable from publisher's website
999			_c22617541 _d22617541